Phase I/II – Other

632 trials 274 recruiting

Filter these 632 trials by condition, country, sponsor and more.

Open in Search →

Safety and efficacy of allogenic adipose tissue-derived mesenchymal stromal cells in patients with epidermolysis bullosa: Clinical trial pha… Ended

2024-516614-37-00 Epidermolysis bullosa congenita 2022-10-12
A clinical study conducted to evaluate the safety, efficacy and tolerability of a drug called liposomal annamycin administered with cytarabi… Ended

2024-516388-10-00 Acute Myeloid Leukemia 2022-09-23
A clinical trial investigating Iloprost as medication to improve bone healing in patients with upper arm bone fracture. Ended

2024-512468-71-00 Proximal humeral fracture 2022-09-21
A PHASE 1/2 STUDY OF ALX148 IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROME (MDS) (ASPEN-02) Ended

2024-513993-23-00 Patients with higher risk myelodysplastic syndrome (MDS 2022-09-21
Phase 1/2 study of Nivolumab and Relatlimab in Combination with Bevacizumab in First-line HCC Ended

2024-510649-33-00 Advanced/metastatic hepatocellular carcinoma (HCC) 2022-09-02
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors Ended

2023-505425-14-00 colorectal cancer 2022-08-11
A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF CYC140, AN ORAL PLK1 INHIBITOR, IN SU… Ended

2024-516290-67-00 ADVANCED SOLID TUMORS AND LYMPHOMA 2022-08-03
Extracorporeal photopheresis as treatment for immune related adverse events after immunotherapy Ended

2024-513614-36-00 Immune related adverse events induced by treatment with 2022-07-27
A Study Evaluating Bemarituzumab in Solid Tumors with FGFR2b Overexpression Ended

2023-505455-44-00 Solid tumours 2022-06-29
Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Ended

2022-502773-41-00 Relapsed/Refractory Classical Hodgkin Lymphoma 2022-06-16
A Study to Assess Safety, Tolerability and Preliminary efficacy of Bexmarilimab in Combination with Standard of Care in Patients with Hemato… Ended

2024-517444-64-00 Chronic Myelomonocytic Leukemia 2022-05-30
PHASE 1/2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE OR IN COMBINATION WITH TOPOTECAN AND CYCL… Ended

2024-511975-14-00 recurrent/refractory Ewing sarcoma 2022-05-26
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling Ended

2023-508617-16-00 Solid Tumors Dependent on KIT or PDGFRA Signaling 2022-05-22
A clinical study to test the safety and efficacy of GB1211 in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSC… Ended

2024-514419-93-00 Study to investigate the safety and efficacy of GB1211 2022-05-19
A Phase 1/2, Open-label, Multicenter Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Fadraciclib (CYC065), an Oral CDK2/9… Ended

2024-516289-12-00 Endometrial cancer, Ovarian cancer, Biliary tract cance 2022-02-24
A clinical trial with nadunolimab in combination with gemcitabine plus carboplatin in patients with advanced triple negative breast cancer. … Ended

2024-512052-38-00 Advanced triple negative breast cancer 2021-12-02
LAVA1207-001/LAVA1207-002 A Phase 1 and 2a open-label trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immun… Ended

2024-515821-27-00 Prostate Cancer 2021-11-30
MENACWY=MEN7B-003 Ended

2023-506449-40-00 Infections, Meningococcal 2021-11-29
A Phase 1/2a study of AFM24 and Atezolizumab in patients with advanced and metastatic cancers Ended

2024-511999-32-00 Advanced/Metastatic EGFR-expressing Cancers 2021-11-19
Phase I/II stUdy of ALoCelyvir in patientS with mEtastaticUveal Melanoma (PULSE-UM) Ended

2024-515032-76-00 mEtastatic Uveal Melanoma 2021-11-10
A clinical study to learn about the effects of a virus that transfers the gene for Glucose- 6-Phosphatase (G6Pase) in adults with Glycogen S… Ended

2023-504004-29-00 Glycogen storage disease type Ia 2021-10-18
A Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer Ended

2024-511158-36-00 Metastatic colorectal cancer 2021-08-05
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participan… Ended

2024-512227-36-00 Advanced solid tumors 2021-07-28
Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain M… Ended

2023-506315-17-00 Advanced melanoma with brain metastases, PD-1 refracto 2021-06-25